Source: PesoRama.
  • PesoRama (PESO) has announced a non-brokered private placement for gross proceeds of up to $2,000,000
  • The pricing of the units is yet to be determined
  • Gross proceeds raised will be used for working capital and general corporate purposes
  • PesoRama operates as Mexico’s only dollar store retailer under the JOi Canadian Stores brand
  • Pesorama Inc. (PESO) opened trading at C$0.14

PesoRama (PESO) has announced a non-brokered private placement for gross proceeds of up to $2,000,000.

The pricing of the units is yet to be determined. Each unit will include one common share and one share purchase warrant. Each warrant will entitle the holder to acquire one additional share.

Gross proceeds raised will be used for working capital and general corporate purposes.

All securities issued will be subject to a statutory four-month hold period.

PesoRama, operating under the JOi Dollar Plus brand, is a Mexican value dollar store retailer. PesoRama launched operations in 2019 in Mexico City and the surrounding areas targeting high-density, high-traffic locations. PesoRama’s 21 stores offer household goods, pet supplies, seasonal products, party supplies, health and beauty, snack food items, confectionery and more.

Pesorama Inc. (PESO) opened trading at C$0.14.


More From The Market Online

“Paw Patrol” owners see a 52-week share price high

Spin Master (TSX:TOY) reported 8.9 per cent revenue growth to US$436.4 million and returned to profitability.

Uber Eats expands grocery delivery network with new U.S. regional retail partners

Uber (NYSE:UBER) Eats added Busch’s Fresh Food Market, Hays, and Lowe’s Market to its grocery delivery marketplace across the U.S.

Cybersecurity stocks worth watching as digital risks continue to evolve

Cybersecurity threats continue to evolve, while recent disruptions highlighted the importance of resilient digital infrastructure.

A small-cap contender looking to challenge the weight-loss drug giants

Structure Therapeutics (NASDAQ:GPCR) is developing an oral weight-loss pill that could offer an alternative to popular injectable treatments.